Company: PDEX
Filing Date: 2025-05-01
Form Type: 10-Q
Source: 0001079973-25-000729
Chunk: 22

Company: PRO DEX INC
Filing Date: 2025-05-01
Form: 10-Q
Item: Item 8
Chunk 22
---
 operations in the new facility during the fourth quarter of fiscal 2023 and believe that the additional capacity
will allow for our continued expected growth.

Our current objectives are focused
primarily on maintaining our relationships with our current medical device customers, investing in research and development activities
to design unique medical devices as well as Pro-Dex branded drivers to leverage our torque-limiting software, expanding our manufacturing
capacity through the continuation of operations at the Franklin Property, and promoting active product development proposals to new and
existing customers for both orthopedic shavers and screw drivers for a multitude of surgical applications, while monitoring closely the
progress of all these individual endeavors. While we expect revenue growth in the future, it may not be a consistent trajectory but rather
periods of incremental growth that current expenditures are helping to create. However, there can be no assurance that we will be successful
in any of these objectives.

19 

Description of Business Operations

Revenue

The
majority of our revenue is derived from designing, developing, and manufacturing surgical
devices for the medical device industry. The proportion of total sales by type is as follows
(in thousands, except percentages):

    Three Months Ended  March 31,  
    Nine Months Ended  March 31, 

    2025  
    2024  
    2025  
    2024 

    % of Revenue  
       
    % of Revenue  
       
    % of Revenue  
       
    % of Revenue 
  
    Net Sales: 

    Medical
device products 
    $11,913  
     68% 
     $9,782  
     68% 
    $ 34,057  
     69% 
    $26,536  
     68%
  
    Industrial and
scientific 
     265  
     2% 
     211  
     1% 
     576  
     1% 
     591  
     2%
  
    Dental and component	 
     45  
     —  
     62  
     1% 
     118  
     —  
     146  
     — 
  
    NRE & Proto-type 
     186  
     1% 
     234  
     2% 
     274  
     1% 
     762